Mobilization of CD34+CD38- hematopoietic stem cells after priming in acute myeloid leukemia

Table 2 Circulating CD34⁺ cell subsets before, during and after intensive chemotherapy

Time	CD34 vs CD38
	CD34+CD38-	CD34+CD38low	CD34+CD38+
At diagnosis (T0)
Median	7.32%	35.45%	56.74%
Mean ± SD	15.40% ± 19.21%	32.35% ± 20.41%	53.81% ± 35.37%
At 4 d (T4)
Median	12.82%	39.15%	37.30%
Mean ± SD	21.17% ± 22.68%	34.01% ± 23.08%	45.11% ± 37.48%
At 8 d (T8)
Median	15.99%	26.21%	36.81%
Mean ± SD	30.14% ± 29.51%	30.28% ± 20.87%	39.06% ± 32.98%
At 10 d (T10)
Median	41.35%	22.99%	18.90%
Mean ± SD	48.18% ± 26.79%	27.86% ± 18.65%	24.29% ± 22.73%
At 15 d (T15)
Median	73.56%	26.18%	3.93%
Mean ± SD	66.42% ± 20.18%	27.33% ± 9.26%	8.05% ± 12.24%
At recovery (TR)
Median	5.37%	32.76%	63.42%
Mean ± SD	10.63% ± 13.81%	29.53% ± 11.23%	61.79% ± 18.39%

TR: Time of cell recovery.